Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial
Journal of the American Academy of Dermatology · 2025-09
DOI: 10.1016/j.jaad.2025.09.031 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2025-09. Verfasst von Larissa Pierri Carvalho Fonseca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, FMB, UNESP, Botucatu, São Paulo, Brazil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, FMB, UNESP, Botucatu, São Paulo, Brazil.
- Farmatec, Porto Alegre, Rio Grande do Sul, Brazil.
- Department of Dermatology, FMB, UNESP, Botucatu, São Paulo, Brazil. Electronic address: dermato.paulo@gmail.com.
Zitieren
APA
Carvalho Fonseca, L. P., Miot, H. A., Prescendo Chaves, C. R., & Müller Ramos, P. (2025). Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.09.031
Vancouver
Carvalho Fonseca LP, Miot HA, Prescendo Chaves CR, Müller Ramos P. Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. Journal of the American Academy of Dermatology. 2025. doi:10.1016/j.jaad.2025.09.031
BibTeX
@article{CarvalhoFonseca2025,
author = {Carvalho Fonseca, Larissa Pierri and Miot, Hélio Amante and Prescendo Chaves, Christine Rachelle and Müller Ramos, Paulo},
title = {Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial},
journal = {Journal of the American Academy of Dermatology},
year = {2025},
doi = {10.1016/j.jaad.2025.09.031}
}
EUVIMED